SEC Form 4 · accession 0001645627-17-000100
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 25, 2017
Accepted (ET)
Jul 27, 2017 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2017 | P | 5,000 | $0.0298 | A | 22,009,389 | D | |
| Common Stock | Jul 25, 2017 | P | 3,000 | $0.0392 | A | 22,012,389 | D | |
| Common Stock | Jul 25, 2017 | P | 2,000 | $0.039 | A | 22,014,389 | D | |
| Common Stock | Jul 25, 2017 | P | 2,000 | $0.039 | A | 22,016,389 | D | |
| Common Stock | Jul 25, 2017 | P | 3,500 | $0.0386 | A | 22,019,889 | D | |
| Common Stock | Jul 25, 2017 | P | 3,500 | $0.0372 | A | 22,023,389 | D | |
| Common Stock | Jul 25, 2017 | P | 2,000 | $0.0376 | A | 22,025,389 | D | |
| Common Stock | Jul 26, 2017 | P | 3,000 | $0.035 | A | 22,028,389 | D | |
| Common Stock | Jul 26, 2017 | P | 3,000 | $0.0385 | A | 22,031,389 | D |
Table II — derivative securities
No Table II lines on this filing.